Study title: Randomized, double-blind, 3-period crossover, exercise challenge study of 50 mcg and 100 mcg HFA-Beclometasone Dipropionate Autohaler and HFA-Placebo dosed once a day in children with asthma*
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: please see report | |||||
| MAH holders: please see report | |||||
| Assessment: | |||||
| Active substance: BECLAMETHASONE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: 1389-BRON | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |